Literature DB >> 22290977

Expression of OXA-type and SFO-1 β-lactamases induces changes in peptidoglycan composition and affects bacterial fitness.

Ana Fernández1, Astrid Pérez, Juan A Ayala, Susana Mallo, Soraya Rumbo-Feal, Maria Tomás, Margarita Poza, Germán Bou.   

Abstract

β-Lactamases and penicillin-binding proteins (PBPs) have evolved from a common ancestor. β-Lactamases are enzymes that degrade β-lactam antibiotics, whereas PBPs are involved in the synthesis and processing of peptidoglycan, which forms an elastic network in the bacterial cell wall. This study analyzed the interaction between β-lactamases and peptidoglycan and the impact on fitness and biofilm production. A representative set of all classes of β-lactamases was cloned in the expression vector pBGS18 under the control of the CTX-M promoter and expressed in Escherichia coli MG1655. The peptidoglycan composition of all clones was evaluated, and quantitative changes were found in E. coli strains expressing OXA-24, OXA-10-like, and SFO-1 (with its upstream regulator AmpR) β-lactamases; the level of cross-linked muropeptides decreased, and their average length increased. These changes were associated with a statistically significant fitness cost, which was demonstrated in both in vitro and in vivo experiments. The observed changes in peptidoglycan may be explained by the presence of residual DD-endopeptidase activity in these β-lactamases, which may result in hydrolysis of the peptide cross bridge. The biological cost associated with these changes provides important data regarding the interaction between β-lactamases and the metabolism of peptidoglycan and may provide an explanation for the epidemiology of these β-lactamases in Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290977      PMCID: PMC3318342          DOI: 10.1128/AAC.05402-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  46 in total

Review 1.  Minimizing potential resistance: a population dynamics view.

Authors:  B R Levin
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

2.  Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.

Authors:  Ana Fernández; Emilia Gil; Mónica Cartelle; Astrid Pérez; Alejandro Beceiro; Susana Mallo; María Mar Tomás; Francisco J Pérez-Llarena; Rosa Villanueva; Germán Bou
Journal:  J Antimicrob Chemother       Date:  2007-03-01       Impact factor: 5.790

3.  A novel OXA-10-like beta-lactamase is present in different Enterobacteriaceae.

Authors:  Ayelén Porto; Juan Ayala; Gabriel Gutkind; José Di Conza
Journal:  Diagn Microbiol Infect Dis       Date:  2009-10-15       Impact factor: 2.803

4.  A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors.

Authors:  Susana Mallo; Francisco J Pérez-Llarena; Fréderic Kerff; Nelson C Soares; Moreno Galleni; Germán Bou
Journal:  J Antimicrob Chemother       Date:  2010-04-09       Impact factor: 5.790

5.  Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii.

Authors:  G Barnaud; G Arlet; C Verdet; O Gaillot; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Biological cost of AmpC production for Salmonella enterica serotype Typhimurium.

Authors:  M I Morosini; J A Ayala; F Baquero; J L Martínez; J Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 8.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 9.  The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis.

Authors:  Eric Sauvage; Frédéric Kerff; Mohammed Terrak; Juan A Ayala; Paulette Charlier
Journal:  FEMS Microbiol Rev       Date:  2008-02-11       Impact factor: 16.408

10.  CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii.

Authors:  Ryuichi Nakano; Ryoichi Okamoto; Yumiko Nakano; Kenichi Kaneko; Naohiro Okitsu; Yoshio Hosaka; Matsuhisa Inoue
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more
  16 in total

Review 1.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

2.  Strong Environment-Genotype Interactions Determine the Fitness Costs of Antibiotic Resistance In Vitro and in an Insect Model of Infection.

Authors:  C James Manktelow; Elitsa Penkova; Lucy Scott; Andrew C Matthews; Ben Raymond
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Synthesis of metallo-β-lactamase VIM-2 is associated with a fitness reduction in Salmonella enterica Serovar Typhimurium.

Authors:  Nicolás F Cordeiro; José A Chabalgoity; Lucía Yim; Rafael Vignoli
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

4.  Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.

Authors:  Myung-Jin Choi; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

5.  Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii.

Authors:  Alejandro Beceiro; Antonio Moreno; Nathalie Fernández; Juán A Vallejo; Jesús Aranda; Ben Adler; Marina Harper; John D Boyce; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

6.  Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Authors:  Nicholas S Britt; David J Ritchie; Marin H Kollef; Carey-Ann D Burnham; Michael J Durkin; Nicholas B Hampton; Scott T Micek
Journal:  Am J Infect Control       Date:  2018-04-26       Impact factor: 2.918

7.  Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro.

Authors:  Chuan-Zhen Zhang; Si-Qi Ren; Man-Xia Chang; Pin-Xian Chen; Huan-Zhong Ding; Hong-Xia Jiang
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

8.  Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study.

Authors:  Dawid Rozenkiewicz; Erika Esteve-Palau; Mar Arenas-Miras; Santiago Grau; Xavier Duran; Luisa Sorlí; María Milagro Montero; Juan P Horcajada
Journal:  Antibiotics (Basel)       Date:  2021-05-15

9.  Diversity of Sequence Types and Impact of Fitness Cost among Carbapenem-Resistant Acinetobacter baumannii Isolates from Tripoli, Libya.

Authors:  Antoine G Abou Fayad; Louis-Patrick Haraoui; Ahmad Sleiman; Mohamad Jaafar; Abdulaziz Zorgani; Ghassan M Matar; Paul G Higgins
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

10.  Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria.

Authors:  Ximin Zeng; Jun Lin
Journal:  Front Microbiol       Date:  2013-05-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.